Conservation max

A confocal image of endothelial cells cultured in one of the microcapillaries of the biochip. Credit: Cellix Ltd." />A confocal image of endothelial cells cultured in one of the microcapillaries of the biochip. Credit: Cellix Ltd. User: Garry Walsh, University of Aberdeen School of Medicine, Scotland. Project: Examining adhesion of eosinophils under conditions of blood flow in the lungs. Problem: Eosinophils are relatively rare and difficult to

Written byJosh P. Roberts
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

User:
Garry Walsh, University of Aberdeen School of Medicine, Scotland.

Project:
Examining adhesion of eosinophils under conditions of blood flow in the lungs.

Problem:
Eosinophils are relatively rare and difficult to isolate. "You don't have very many to play with in your experiment," Walsh says. He needed a device that can handle a small number of cells in small volumes.

Solution: Five years ago, Walsh connected with engineers from Trinity College, Dublin, who asked him to help test a platform with standardized channels and precision fluidic control; the engineers later commercialized the platform through a spin-off company, Cellix. They developed a disposable microfluidic chip containing eight parallel, 400-μm wide microchannels - roughly the dimensions of a postcapillary venule. Walsh coats the channels with adhesion molecules, then flows eosinophils through them. Some researchers create homemade versions of the device from finely pulled capillary tubes and syringe pumps, he says, but he ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies